Alan Menter News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Alan Menter. Real-time updates on events, politics, business and more.

Switching with Adalimumab Biosimilar Maintains Benefit for Plaque Psoriasis

November 7, 2023

Trial data support multiple switching between biosimilar and reference product over a 48-week course for the treatment of psoriasis.

Baylor Scott White Alan Menter Drug Administration Baylor Scott Psoriasis Area Severity Index Global Physicians Assessment

Source: hcplive.com

Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis

December 1, 2021

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced positive top-line results from the DISCREET trial, a Phase 3, multicenter, randomized, placebo-controlled,...

United States Puerto Rico Carsten Henneges Michael Strapazon Alison Potts Bleakman Alan Menter

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Alan Menter News Today

Switching with Adalimumab Biosimilar Maintains Benefit for Plaque Psoriasis

Amgen Announces Positive Top-Line Results From Otezla&#xAE; (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis

Explore More Categories

Amgen Announces Positive Top-Line Results From Otezla® (apremilast) Phase 3 DISCREET Study In Moderate To Severe Genital Psoriasis